These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Inhibitory effect of quinacrine on myocardial reactive hyperemia in the dog. Kimura T; Satoh S J Pharmacol Exp Ther; 1985 Jan; 232(1):269-74. PubMed ID: 3965697 [TBL] [Abstract][Full Text] [Related]
6. Cardiotonic and coronary vasodilator responses to milrinone, forskolin, and analog P87-7692 in the anesthetized dog. Lebedinsky Y; Nordstrom ST; Aschoff SE; Kapples JF; O'Malley GJ; Kosley RW; Fielding S; Hubbard JW J Cardiovasc Pharmacol; 1992 May; 19(5):779-89. PubMed ID: 1381777 [TBL] [Abstract][Full Text] [Related]
7. Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium. Imai H; Matsui K; Ochi S; Nakazawa M; Nakagawa Y; Imai S Arzneimittelforschung; 1987 Dec; 37(12):1348-52. PubMed ID: 3449062 [TBL] [Abstract][Full Text] [Related]
11. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046. Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223 [TBL] [Abstract][Full Text] [Related]
12. Vasodilator action of KB-944, a new calcium antagonist. Morita T; Yoshino K; Kanazawa T; Ito K; Nose T Arzneimittelforschung; 1982; 32(9):1037-42. PubMed ID: 6890822 [TBL] [Abstract][Full Text] [Related]
13. Comparative profile of vasodilation by CVT-3146, a novel A2A receptor agonist, and adenosine in conscious dogs. Zhao G; Linke A; Xu X; Ochoa M; Belloni F; Belardinelli L; Hintze TH J Pharmacol Exp Ther; 2003 Oct; 307(1):182-9. PubMed ID: 12954805 [TBL] [Abstract][Full Text] [Related]
14. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity. Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652 [TBL] [Abstract][Full Text] [Related]
15. Effect of platelet-activating factor on coronary circulation of the domestic pig. Feuerstein G; Boyd LM; Ezra D; Goldstein RE Am J Physiol; 1984 Mar; 246(3 Pt 2):H466-71. PubMed ID: 6703081 [TBL] [Abstract][Full Text] [Related]
17. Effects of prostaglandin synthesis inhibition on sympathetic-and parasympathetic-mediated coronary hemodynamic responses. Trimarco B; Cuocolo A; Ricciardelli B; Patrignani P; Volpe M; de Luca N; Condorelli M J Pharmacol Exp Ther; 1986 May; 237(2):589-99. PubMed ID: 3084760 [TBL] [Abstract][Full Text] [Related]
18. The effects of sympathetic stimulation and adenosine on coronary circulation and heart function in diabetes mellitus. Koltai MZ; Jermendy G; Kiss V; Wagner M; Pogátsa G Acta Physiol Hung; 1984; 63(2):119-25. PubMed ID: 6741561 [TBL] [Abstract][Full Text] [Related]
19. The cardiac effects of prostaglandins and their modification by the prostaglandin antagonist N-0164. Allan G; Levi R J Pharmacol Exp Ther; 1980 Jul; 214(1):45-9. PubMed ID: 6993659 [TBL] [Abstract][Full Text] [Related]
20. Dose-related effects of intracoronary application of nisoldipine on central and peripheral circulatory parameters. Schartl M; Heidelmeyer C; Veit S; Dougherty C; Brückner JB Arzneimittelforschung; 1989 Jun; 39(6):682-5. PubMed ID: 2775335 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]